Drug adverse event reports (FAERS)

Injection site pain, Erythema, Scab +7

Drugs: UNAPPROVED DRUG COSMETIC PRODUCTS, STEM CELL, EXOSOME, GROWTH FACTOR OR TISSUE DERIVED UNAPPROVED PRODUCT, ZYRTEC +5

SeriousDisabilityReport 26884216
Safetyreportversion
1
Safetyreportid
26884216
Primarysourcecountry
US
Transmissiondateformat
102
Transmissiondate
20260709
Reporttype
1
Serious
1
Seriousnessdeath
2
Seriousnesslifethreatening
2
Seriousnesshospitalization
2
Seriousnessdisabling
1
Seriousnesscongenitalanomali
2
Seriousnessother
2
Receivedateformat
102
Receivedate
20260615
Receiptdateformat
102
Receiptdate
20260615
Fulfillexpeditecriteria
3
Authoritynumb
826382
Primarysource
Reportercountry
US
Qualification
5
Sender
Sendertype
6
Senderorganization
FDA-CTU
Receiver
Receivertype
6
Receiverorganization
FDA
Patient
Patientonsetage
57
Patientonsetageunit
801
Patientweight
51.75
Patientsex
2
Reaction
  1. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Injection site pain
  2. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Erythema
  3. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Scab
  4. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Skin burning sensation
  5. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Skin discolouration
  6. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Sepsis
  7. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Localised oedema
  8. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Erythema
  9. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Pruritus
  10. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Tenderness
  11. Reactionmeddraversionpt
    29.0
    Reactionmeddrapt
    Skin induration
Drug
  1. Drugcharacterization
    1
    Medicinalproduct
    UNAPPROVED DRUG COSMETIC PRODUCTS
    Drugdosagetext
    TOPICAL
    Drugadministrationroute
    061
    Drugstartdateformat
    102
    Drugstartdate
    20260602
    Drugenddateformat
    102
    Drugenddate
    20260602
    Drugadditional
    2
    Activesubstance
    Activesubstancename
    UNAPPROVED DRUG COSMETIC PRODUCTS
  2. Drugcharacterization
    1
    Medicinalproduct
    UNAPPROVED DRUG COSMETIC PRODUCTS
    Activesubstance
    Activesubstancename
    UNAPPROVED DRUG COSMETIC PRODUCTS
  3. Drugcharacterization
    1
    Medicinalproduct
    STEM CELL, EXOSOME, GROWTH FACTOR OR TISSUE DERIVED UNAPPROVED PRODUCT
    Activesubstance
    Activesubstancename
    STEM CELL, EXOSOME, GROWTH FACTOR OR TISSUE DERIVED UNAPPROVED PRODUCTS
  4. Drugcharacterization
    2
    Medicinalproduct
    ZYRTEC
    Activesubstance
    Activesubstancename
    CETIRIZINE HYDROCHLORIDE
    Harmonized identifiers (openFDA)
    Application number
    NDA021621
    Brand name
    ZYRTEC
    Generic name
    CETIRIZINE HYDROCHLORIDE
    Manufacturer name
    Kenvue Brands LLC
    Product NDC
    50580-753
    Product type
    HUMAN OTC DRUG
    Route
    ORAL
    Substance name
    CETIRIZINE HYDROCHLORIDE
    RxCUI
    1014674, 1020022
    SPL ID
    506ace58-15cc-77b4-e063-6394a90a0813
    SPL set ID
    dc613bd5-70fd-1d9b-e053-2995a90a41cd
    Package NDC
    50580-753-24
    UNII
    64O047KTOA
  5. Drugcharacterization
    2
    Medicinalproduct
    DOXYCYCLINE
    Activesubstance
    Activesubstancename
    DOXYCYCLINE
    Harmonized identifiers (openFDA)
    Application number
    ANDA201678, ANDA204234, ANDA065053, ANDA217098, ANDA218753, ANDA210664, ANDA065285, ANDA218034, ANDA217674, NDA050805, ANDA065454, ANDA210381, ANDA091605, ANDA217487, ANDA065055, ANDA209165, ANDA204446, ANDA209582, ANDA062992, ANDA205115, ANDA065070, ANDA209402, ANDA062475, ANDA217854, ANDA215583, NDA050641, ANDA217794, ANDA065356, ANDA219978, ANDA207289, ANDA218888, ANDA217972, ANDA216631, ANDA216690, ANDA218053, ANDA091406, ANDA207757
    Brand name
    DOXYCYCLINE, DOXYCYCLINE DOXYCYCLINE, ORACEA, DOXY 100, DOXYCYCLINE HYCLATE
    Generic name
    DOXYCYCLINE, DOXYCYCLINE HYCLATE
    Manufacturer name
    Lupin Pharmaceuticals, Inc., Sun Pharmaceutical Industries, Inc., Solco Healthcare US,LLC, Dr. Reddy's Laboratories, Inc., Acella Pharmaceuticals, LLC, Lannett Company, Inc., Dr.Reddys Laboratories Inc, Alembic Pharmaceuticals Limited, Galderma Laboratories, L.P., Chartwell Governmental & Specialty RX, LLC, Macleods Pharmaceuticals Limited, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., Chartwell RX, LLC, Amneal Pharmaceuticals LLC, Strides Pharma Science Limited, Lupin Pharmaceuticals,Inc., Zydus Pharmaceuticals USA Inc., Hikma Pharmaceuticals USA Inc., Cranbury Pharmaceuticals, LLC, Fresenius Kabi USA, LLC, Alembic Pharmaceuticals Inc., Avenacy Inc., JVET PHARMACEUTICALS LLC, Wellhouse Pharma, LLC, Zydus Lifesciences Limited, Mayne Pharma Inc., Sun Pharmaceutical Industries Inc., AiPing Pharmaceutical, Inc., Piramal Critical Care Inc, Gland Pharma Limited, Amneal Pharmaceuticals NY LLC, FOSUN PHARMA USA INC, Camber Pharmaceuticals, Inc., Steriscience Specialties Private Limited, Par Health USA, LLC, Meitheal Pharmaceuticals Inc., Mylan Institutional LLC
    Product NDC
    68180-657, 68180-650, 68180-651, 68180-652, 63304-614, 63304-615, 63304-616, 43547-590, 43598-086, 42192-501, 0527-1335, 0527-1535, 0527-1338, 0527-1537, 43598-457, 46708-785, 0299-3822, 68999-417, 68999-625, 68999-626, 68999-984, 68999-985, 33342-346, 23155-133, 23155-134, 23155-135, 23155-136, 62135-725, 62135-726, 70121-1616, 64380-179, 64380-180, 64380-181, 46708-249, 46708-250, 43386-790, 43386-791, 43386-792, 70710-1121, 70710-1122 +51 more
    Product type
    HUMAN PRESCRIPTION DRUG
    Route
    ORAL, INTRAVENOUS
    Substance name
    DOXYCYCLINE, DOXYCYCLINE HYCLATE
    RxCUI
    1650030, 700408, 1649401, 1649990, 901399, 310027, 1650143, 1649429, 1650142, 1650444, 1652673, 901401, 1649405, 1649988, 1652674, 728207, 544840, 1998483
    SPL ID
    6e5c9f41-4304-4121-845f-b894a4fd5d95, 771f820a-2e1b-4a25-91cb-ba7a068abc70, 338488d1-e9d8-6b00-e063-6294a90a37c0, 1d96d5b0-a628-437f-8150-b3ee29c15fae, d81118bc-54c2-51cd-4ddd-d3afcf12ddf8, 5957035d-19d3-b251-e063-6394a90a0561, dc960a6c-1b09-4049-a1e9-0109576b1d30, 3fea16fe-25ae-5b3c-8b49-686e6afc69c7, 8e78dc54-8322-435d-8879-4bfe37f1b98c, 67eef1b6-593a-4277-abd3-f3e60e7557b0, 40076faf-09c3-f4ab-e063-6394a90ab3c1, 79ccf038-ab96-4ea7-a7cf-c56be45e3f57, ec6854e5-3f41-4b8f-be77-49e3bd19f7c4, 45899031-dfb9-a7d6-e063-6294a90a80c6, b34b4a98-fd44-4569-a530-0bc4f9046a75, 170d0f42-f785-4f77-a5cf-45c1e8c45f1e, 7bd9362d-42fd-4f01-bed9-3797d0c1d6ee, a3ed2ee4-163c-4167-abf2-59a7e1d66a61, 24db9fe2-5c05-42d0-b113-307484699e9a, fa074f92-7cf9-4290-8cf7-7a2b94447cf3, 9486a93f-bc2a-444a-a8d4-3bce410d21c7, 27575633-ff92-45c4-a365-510f656d68dc, 916c7c28-037e-40aa-a97f-d9d5c4fc43f9, b4654993-19ce-4911-a0d0-4836f357223d, c89c0388-cc32-4fa4-a954-678d7448d4c1, 2dbadeae-fea5-4a18-90cf-ee669b8e71cb, ed95709e-2a1a-4deb-88bd-5b99f02b7a26, 575c46be-1210-fb40-e063-6294a90a8d0f, 1f788250-9643-4c64-bb4e-4dfefabb8c01, 4600dc6a-950d-4d84-aed9-da01fbd0db8b, d9de3252-a876-482e-be60-0a47eb985aa8, 8aa2cef1-9f23-46ed-bd30-d54812779f6b, fd417a50-69b5-40b4-89fd-58aea77ab547, ed0afbd5-2f21-48d3-a1a2-a253b4ad707a, 3f7348fd-b9f3-a104-e063-6394a90a0642, ca2211dc-d46a-4069-8aa3-a146475427a2, d114fe27-0716-4e35-be8d-e69bd5a3cbb5, 22ec807c-14e3-4b73-baa8-931ade7d3203, 31ba285b-5aef-ff76-e063-6294a90a9321, 44923ffd-23df-ccf8-e063-6394a90aeff5 +11 more
    SPL set ID
    e0e80435-1b6a-4361-8c8a-e432f8f23a1b, bcc65910-30d8-4807-ab61-607a56382924, 829dbd3d-5c2b-47b8-96a5-423af78c93b9, 99305d9a-d058-45d6-8dec-19308b1fc5a9, c0206e91-d87f-311c-80dc-aad543d001e8, 3fb9f5ad-90a2-4858-bc34-f800d8b2fa90, 4999bbd9-44ed-4749-9730-be2337bdf490, 7a28cce1-4805-b3d1-4484-e7a49c597660, 8e78dc54-8322-435d-8879-4bfe37f1b98c, aa15c93a-ff4c-447a-8a21-96da506d8997, b8486639-7eb9-4610-9cd4-0e922045d592, 10aca485-850b-4c82-bb7e-5fac2d7a62ce, 2bcde264-5f6f-47f6-ae2e-1b7010deacf7, 5bebf320-1395-43b9-9404-fe479d70b240, 95ba4d68-2519-4edd-b9a2-5cd2fd00b250, 9e710113-f25e-46fb-8327-7a8e649613a2, 3dfa486c-4665-4882-93ac-9259708f899c, 6512bf22-c211-4127-a8c8-2419656580f6, bc321932-b600-4659-a499-1853991b4ab9, 2aa835bd-6fac-46b8-9716-9622fb550c8f, fef9580d-8850-4cbb-89eb-2b4d40ee59c9, 3b9888a2-ca16-43f7-ab6d-f03188ec2c0d, 43ceb0ee-268a-424c-a6a8-88e824c5ed04, b256babb-1bba-4b0c-8837-d13ba3af7659, a50e953d-447b-4b66-b567-04586174d3f9, 429813b4-0223-4d85-a844-b1227ff63b1e, ed95709e-2a1a-4deb-88bd-5b99f02b7a26, 57f97f68-11fb-4900-9efb-ca3b00818d8e, c886b2e4-494a-4325-abaf-981fc3d01c66, 0e6b3e17-aeee-4910-8e94-c7ac925b9cca, aa01035d-8b4a-4fdc-bfdf-2b39df0d8fc9, 2946fc05-78e5-4669-85d1-3a3979eceae0, 8224b9c5-5c4b-4dda-bc58-47b6604c2884, a894f4be-19e5-4785-8d0b-5e0d5626300e, fd672959-014f-8300-e053-6394a90a5ec5, 6a5780a9-4548-427c-972a-ef49fdcbc84d, 49ecbf95-58e8-4f3c-b5d5-650a15d866cb, b0894010-39bd-459f-8563-cf83343105ee, fa3fbb09-b830-60c5-e053-6394a90a4165, 0faee97d-2707-48fe-a739-143cd1a1c4e3 +11 more
    Package NDC
    68180-657-01, 68180-650-01, 68180-651-01, 68180-652-29, 68180-652-08, 63304-614-20, 63304-614-05, 63304-614-01, 63304-614-13, 63304-615-05, 63304-615-11, 63304-615-01, 63304-616-20, 63304-616-05, 63304-616-01, 63304-616-13, 63304-616-50, 43547-590-03, 43598-086-58, 42192-501-50, 42192-501-05, 0527-1335-01, 0527-1535-01, 0527-1338-50, 0527-1338-25, 0527-1537-30, 0527-1537-01, 43598-457-30, 46708-785-30, 0299-3822-30, 0299-3822-06, 0299-3822-05, 0299-3822-04, 0299-3822-02, 0299-3822-07, 68999-625-60, 68999-626-02, 68999-626-28, 68999-626-30, 68999-626-50 +185 more
    Nui
    N0000175882, N0000007948
    Pharm class epc
    Tetracycline-class Drug [EPC]
    Pharm class cs
    Tetracyclines [Chemical/Ingredient]
    UNII
    N12000U13O, 19XTS3T51U
  6. Drugcharacterization
    2
    Medicinalproduct
    METHYLPREDNISOLONE
    Activesubstance
    Activesubstancename
    METHYLPREDNISOLONE
    Harmonized identifiers (openFDA)
    Application number
    NDA011153, ANDA204072, ANDA040183, ANDA206751, ANDA212396, ANDA207549, ANDA209097
    Brand name
    MEDROL, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE
    Generic name
    METHYLPREDNISOLONE
    Manufacturer name
    Pharmacia & Upjohn Company LLC, Epic Pharma, LLC, Par Health USA, LLC, Mylan Pharmaceuticals Inc., Zydus Lifesciences Limited, BluePoint Laboratories, Tianjin Kingyork Pharmaceuticals Co., Ltd, Tianjin Tianyao Pharmaceuticals Co., Ltd., Zydus Pharmaceuticals USA Inc., Amneal Pharmaceuticals LLC, Chartwell RX, LLC
    Product NDC
    0009-0020, 0009-0049, 0009-0056, 0009-0022, 0009-0073, 0009-0176, 42806-400, 0603-4593, 59762-0049, 59762-4440, 59762-0050, 59762-0051, 70771-1348, 70771-1349, 70771-1350, 70771-1351, 68001-624, 82094-401, 82094-402, 82094-403, 82094-404, 82094-405, 57582-101, 68382-916, 68382-917, 68382-918, 68382-919, 70121-1000, 70121-1001, 62135-759, 62135-760, 62135-761, 62135-762, 62135-763
    Product type
    HUMAN PRESCRIPTION DRUG
    Route
    ORAL, INTRAMUSCULAR, INTRAVENOUS
    Substance name
    METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE
    RxCUI
    197969, 197971, 197973, 207136, 207137, 207138, 207141, 259966, 260330, 328161, 762675, 834023, 311659, 314099, 1357886, 1743704
    SPL ID
    e4a8e5b4-af77-4eca-92de-cd0982969b82, a7416892-37af-4d45-ab52-5e5700e6b3e5, 61876830-b7d4-464d-b825-75e7a08627e3, bc3419a0-22a3-4eaf-a4f2-3133e9380663, 99239c7c-b107-454a-8cee-9dd6cbd5647b, 5267c1af-043e-c1e6-e063-6294a90a42d1, 94c8ce6b-7622-4d1f-8b54-0ce959752ae5, 925bd0e3-3f69-411c-ad1e-7db010ec17be, 6cebff10-362f-41a7-8f66-3d9e878760fd, 3eb27de6-9e1c-4ef4-bb31-2458b9360582, 225669c1-9479-52eb-e063-6394a90a649b
    SPL set ID
    39d5270b-d957-4821-93d6-501b7b9f02d4, b1908c2a-c596-4e2a-b2bd-0745d4fea31a, c84cf5e6-746d-41fb-b3d8-2c0b8ba989af, 22dd75d6-f89a-44f7-8ca6-b64c4e9806dd, fe9c15b5-4264-45f1-87b5-f7e1d6e6ddee, 7092df48-4904-4047-9916-e585417a216f, 77a8d96c-37df-4f3a-9757-b2d4131ff82b, e09eefd2-f423-40cb-87b6-3ee97e7f831b, eaa9c932-c659-4ef6-bf5a-186545d87320, e86fbda8-00e4-4d54-841a-59dea6c15e70, bdd048bb-7e6c-45c7-b51a-075e83ca9f5b
    Package NDC
    0009-0049-02, 0009-0056-02, 0009-0056-04, 0009-0022-01, 0009-0073-01, 0009-0176-01, 0009-0020-01, 42806-400-01, 42806-400-21, 0603-4593-21, 0603-4593-15, 59762-4440-3, 59762-4440-2, 59762-0049-1, 59762-0050-1, 59762-0051-1, 70771-1348-1, 70771-1348-5, 70771-1348-3, 70771-1349-8, 70771-1349-1, 70771-1349-5, 70771-1349-2, 70771-1349-4, 70771-1350-7, 70771-1350-1, 70771-1350-5, 70771-1350-2, 70771-1350-4, 70771-1351-8, 70771-1351-1, 70771-1351-5, 70771-1351-2, 70771-1351-4, 68001-624-01, 82094-401-01, 82094-401-50, 82094-402-01, 82094-402-50, 82094-403-01 +35 more
    Nui
    N0000175576, N0000175450
    Pharm class epc
    Corticosteroid [EPC]
    Pharm class moa
    Corticosteroid Hormone Receptor Agonists [MoA]
    UNII
    X4W7ZR7023, LEC9GKY20K
  7. Drugcharacterization
    2
    Medicinalproduct
    BERBERINE
    Activesubstance
    Activesubstancename
    BERBERINE
  8. Drugcharacterization
    2
    Medicinalproduct
    COENZYME Q10
    Activesubstance
    Activesubstancename
    DIETARY SUPPLEMENT\UBIDECARENONE
  9. Drugcharacterization
    2
    Medicinalproduct
    VITAMIN D
    Activesubstance
    Activesubstancename
    VITAMIN D NOS
    Harmonized identifiers (openFDA)
    Application number
    ANDA090455
    Brand name
    VITAMIN D
    Generic name
    ERGOCALCIFEROL
    Manufacturer name
    Strides Pharma Science Limited
    Product NDC
    64380-737
    Product type
    HUMAN PRESCRIPTION DRUG
    Route
    ORAL
    Substance name
    ERGOCALCIFEROL
    RxCUI
    1367410
    SPL ID
    1cc589f7-cd6d-40a6-8fce-c965e8945eae
    SPL set ID
    2c4c0a36-12cf-444d-9d57-de983eef4d36
    Package NDC
    64380-737-06, 64380-737-25
    Nui
    M0007651, N0000175909
    Pharm class cs
    Ergocalciferols [CS]
    Pharm class epc
    Provitamin D2 Compound [EPC]
    UNII
    VS041H42XC
Summary
Narrativeincludeclinical
CASE EVENT DATE: 20260602
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

How to read this: Each report says someone told FDA an event happened while a product was used. A report does not show the product caused it, and counts rise and fall with how many people report. Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.